Worldwide
Established subscription and lead-generation platform seeking capital for US expansion, supported by an exclusive partnership, recurring income and completed pilot programme. £1.5M($1.98M) investment. More details »
Category-leading AI-powered biohacking app with recurring B2C subscriptions, proprietary technology, strong growth and a global audience. More details »
Advertisement